Surface Treatment of SARS-Infected Lungs

PCT/SG03/00145

Claims A

(Use for medicine patent by patent-law of country only)

1. The liquid medicine name of “Surface Treatment of SARS–Infected Lungs” is Per Fluoro Chemicals (PFC) mixing ozone forming a medicine.

2. In the claim 1, the liquid includes all liquids of fluorine element.

3. In the claim 1, includes any substitute liquid to mixing ozone or the single oxygen is decompose by other element.

4. In the Claim 1 of liquid medicines include the option of mixing any chemical that might kill or restrain the germs, for instance any antibiotics or other bactericide and so on.

5. In the Claim 1, includes any other lung diseases and SARS inflammation.

Claims B

(Use for medicine and methods of medical treatment patent by patent-law

of country, for instance US patent office and so on.)

1. The main characteristic of the “Surface Treatment of SARS–Infected Lungs” is to inject sterilizing liquid into the lung lobes.

2. “Surface Treatment of SARS–Infected Lungs” in claim1, the formal name for the medicine of sterilizing liquid is Fluoro Chemicals (PFC) adding ozone forming a medicine.

3. “Surface Treatment of SARS–Infected Lungs” in claim1, including any other lung diseases and SARS inflammation.

4. “Surface Treatment of SARS–Infected Lungs” in claim1, to add antibiotics or other bactericide into the sterilizing liquid to suppress or to kill the virus.

5. In the claim 1, the liquid includes all liquids of fluorine element.

6. In the claim 1, includes any substitute liquid to mixing ozone or the single oxygen is decompose by other element.

7. The claims include a brand-new medical theories that is“The handling effect of difference in temperature”for cure cancer.

8. The claims include a brand-new methods of medical treatment of “Frozen-Therapy”for kill dead the cancer-cell.